{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:13:59Z","timestamp":1778746439810,"version":"3.51.4"},"reference-count":43,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15571","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T12:13:32Z","timestamp":1775132012000},"page":"1-9","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive treatment for intracranial invasive sinonasal intestinal\u2011type adenocarcinoma with a focus on radiotherapy dosage and immunological combination therapy: A case report"],"prefix":"10.3892","volume":"31","author":[{"given":"Lianlian","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Oncology, The General Hospital of Western Theater Command, Chengdu, Sichuan 610083, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Oncology, Dazhu County People's Hospital, Dazhou, Sichuan 635199, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The General Hospital of Western Theater Command, Chengdu, Sichuan 610083, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyan","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Oncology, The General Hospital of Western Theater Command, Chengdu, Sichuan 610083, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiongwen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Dazhu County People's Hospital, Dazhou, Sichuan 635199, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, The General Hospital of Western Theater Command, Chengdu, Sichuan 610083, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihui","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, The General Hospital of Western Theater Command, Chengdu, Sichuan 610083, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"key20260514105607_b1-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12105-017-0800-7","article-title":"Intestinal-type adenocarcinoma: Classification, immunophenotype, molecular features and differential diagnosis","volume":"11","author":"Leivo","year":"2017","journal-title":"Head Neck Pathol"},{"key":"key20260514105607_b2-ol-31-6-15571","first-page":"e56067","article-title":"Sinonasal adenocarcinoma: Clinicopathological characterization and prognostic factors","volume":"16","author":"Baptista Freitas","year":"2024","journal-title":"Cureus"},{"key":"key20260514105607_b3-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1136\/jcp.2004.016964","article-title":"Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma","volume":"57","author":"Kennedy","year":"2004","journal-title":"J Clin Pathol"},{"key":"key20260514105607_b4-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12105-016-0694-9","article-title":"Sinonasal adenocarcinoma: Update on classification, immunophenotype and molecular features","volume":"10","author":"Leivo","year":"2016","journal-title":"Head Neck Pathol"},{"key":"key20260514105607_b5-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1102\/1470-5206.2012.0015","article-title":"Imaging of sinonasal tumours","volume":"12","author":"Eggesb\u00f8","year":"2012","journal-title":"Cancer Imaging"},{"key":"key20260514105607_b6-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/MOO.0000000000000445","article-title":"Intestinal-type adenocarcinoma of the sinonasal tract: An update","volume":"26","author":"Rampinelli","year":"2018","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"key20260514105607_b7-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/hed.24639","article-title":"ACR appropriateness criteria\u00ae nasal cavity and paranasal sinus cancers","volume":"39","author":"Siddiqui","year":"2017","journal-title":"Head Neck"},{"key":"key20260514105607_b8-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"E2267","DOI":"10.1002\/hed.24182","article-title":"Endoscopic nasal versus open approach for the management of sinonasal adenocarcinoma: A pooled-analysis of 1826 patients","volume":"38","author":"Meccariello","year":"2016","journal-title":"Head Neck"},{"key":"key20260514105607_b9-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1007\/s00405-024-08447-w","article-title":"Choice of surgery in intestinal-type adenocarcinoma of the sinonasal tract: A long-term comparative study","volume":"281","author":"Vermassen","year":"2024","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"key20260514105607_b10-ol-31-6-15571","first-page":"347","article-title":"Clinical outcome in patients with large sinonasal tumors with intracranial extension","volume":"85","author":"Keizer","year":"2023","journal-title":"J Neurol Surg B Skull Base"},{"key":"key20260514105607_b11-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1200\/JCO.2004.05.071","article-title":"Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinoma","volume":"22","author":"Licitra","year":"2004","journal-title":"J Clin Oncol"},{"key":"key20260514105607_b12-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.bulcan.2022.10.004","article-title":"5-Fluorouracil with oxaliplatin and\/or irinotecan for advanced sinonasal intestinal-type adenocarcinoma (ITAC)","volume":"110","author":"Sarradin","year":"2023","journal-title":"Bull Cancer"},{"key":"key20260514105607_b13-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.oraloncology.2012.12.011","article-title":"Tp53 status as guide for the management of ethmoid sinus intestinal-type adenocarcinoma","volume":"49","author":"Bossi","year":"2013","journal-title":"Oral Oncol"},{"key":"key20260514105607_b14-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.3390\/ijms14035170","article-title":"EGFR expression and KRAS and BRAF mutational status in intestinal-type sinonasal adenocarcinoma","volume":"14","author":"Szablewski","year":"2013","journal-title":"Int J Mol Sci"},{"key":"key20260514105607_b15-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.semcancer.2019.09.016","article-title":"Translational genomics of sinonasal cancers","volume":"61","author":"Hermsen","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"key20260514105607_b16-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"899","DOI":"10.6004\/jnccn.2020.7590","article-title":"Evolving role of immunotherapy in recurrent metastatic head and neck cancer","volume":"18","author":"Le","year":"2020","journal-title":"J Natl Compr Cancer Netw"},{"key":"key20260514105607_b17-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1200\/JCO.21.02508","article-title":"Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: Updated results of the phase III KEYNOTE-048 study","volume":"41","author":"Harrington","year":"2023","journal-title":"J Clin Oncol"},{"key":"key20260514105607_b18-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.annonc.2024.11.012","article-title":"Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study","volume":"36","author":"Andr\u00e9","year":"2025","journal-title":"Ann Oncol"},{"key":"key20260514105607_b19-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/hed.25067","article-title":"Programmed death ligand-1 expression as immunotherapeutic target in sinonasal cancer","volume":"40","author":"Riobello","year":"2018","journal-title":"Head Neck"},{"key":"key20260514105607_b20-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"e255021","DOI":"10.1136\/bcr-2023-255021","article-title":"Low-dose nivolumab and cabozantinib in recurrent intestinal-type papillary adenocarcinoma of the sinonasal region","volume":"16","author":"Thomas","year":"2023","journal-title":"BMJ Case Rep"},{"key":"key20260514105607_b21-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00432-024-05744-z","article-title":"A case of high-grade non-intestinal paranasal sinus adenocarcinoma primary in the maxillary sinus: Targeted therapy after postoperative immunocombination with chemotherapy","volume":"150","author":"Yang","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20260514105607_b22-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.pathol.2020.10.007","article-title":"Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: A guide to immunohistochemistry implementation and interpretation","volume":"53","author":"Paver","year":"2021","journal-title":"Pathology"},{"key":"key20260514105607_b23-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"e27341","DOI":"10.1097\/MD.0000000000027341","article-title":"Decreasing recurrence and increasing survival rates in patients of ethmoid or sphenoid intestinal-type adenocarcinomas: Systematic review and meta-analysis with 1126 cases","volume":"100","author":"Huang","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"key20260514105607_b24-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1002\/hed.27694","article-title":"Next-generation sequencing reveals remarkable genetic stability in primary and corresponding recurrent intestinal-type sinonasal adenocarcinoma","volume":"46","author":"Riobello","year":"2024","journal-title":"Head Neck"},{"key":"key20260514105607_b25-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/hed.27032","article-title":"Descriptive analysis of recurrences of nasal intestinal-type adenocarcinomas after radiotherapy","volume":"44","author":"Abu-Shama","year":"2022","journal-title":"Head Neck"},{"key":"key20260514105607_b26-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"1522113","DOI":"10.3389\/fonc.2025.1522113","article-title":"Long-term outcomes of endoscopic resection and tailored adjuvant radiotherapy for sinonasal intestinal-type adenocarcinoma: A historical single-center cohort study in 200 patients","volume":"15","author":"Parys","year":"2025","journal-title":"Front Oncol"},{"key":"key20260514105607_b27-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"37115","DOI":"10.1038\/s41598-025-21046-x","article-title":"A retrospective analysis of patients with primary sinonasal adenocarcinoma underwent radiotherapy running title: Radiotherapy for sinonasal adenocarcinoma","volume":"15","author":"Wang","year":"2025","journal-title":"Sci Rep"},{"key":"key20260514105607_b28-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"3","DOI":"10.21037\/tro.2017.12.01","article-title":"Intensity-modulated radiation therapy for a sinonasal intestinal-type adenocarcinoma patient: A rare case report","volume":"1","author":"Hsu","year":"2017","journal-title":"Ther Radiol Oncol"},{"key":"key20260514105607_b29-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1002\/hed.24416","article-title":"Intestinal-type sinonasal adenocarcinomas: The road to molecular diagnosis and personalized treatment","volume":"38","author":"Hoeben","year":"2016","journal-title":"Head Neck"},{"key":"key20260514105607_b30-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/hed.23660","article-title":"Endoscopic resection followed by adjuvant radiotherapy for sinonasal intestinal-type adenocarcinoma: Retrospective analysis of 30 consecutive patients","volume":"37","author":"Antognoni","year":"2015","journal-title":"Head Neck"},{"key":"key20260514105607_b31-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13014-016-0595-9","article-title":"Intensity modulated radiation therapy (IMRT) for sinonasal tumors: A single center long-term clinical analysis","volume":"11","author":"Askoxylakis","year":"2016","journal-title":"Radiat Oncol"},{"key":"key20260514105607_b32-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"200","DOI":"10.14338\/IJPT-20-00068.1","article-title":"Long-term outcomes from proton therapy for sinonasal cancers","volume":"8","author":"Dagan","year":"2021","journal-title":"Int J Part Ther"},{"key":"key20260514105607_b33-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.3390\/cancers14112678","article-title":"A patient selection approach based on NTCP models and DVH parameters for definitive proton therapy in locally advanced sinonasal cancer patients","volume":"14","author":"Mirandola","year":"2022","journal-title":"Cancers (Basel)"},{"key":"key20260514105607_b34-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3892\/ol.2015.3214","article-title":"Proton beam therapy for locally advanced and unresectable (T4bN0M0) squamous cell carcinoma of the ethmoid sinus: A report of seven cases and a literature review","volume":"10","author":"Saito","year":"2015","journal-title":"Oncol Lett"},{"key":"key20260514105607_b35-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1748-717X-6-30","article-title":"Carbon ion therapy for advanced sinonasal malignancies: Feasibility and acute toxicity","volume":"6","author":"Jensen","year":"2011","journal-title":"Radiat Oncol"},{"key":"key20260514105607_b36-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.1158\/1078-0432.CCR-23-3775","article-title":"Tumor-infiltrating lymphocytes in necrotic tumors after melanoma neoadjuvant anti-PD-1 therapy correlate with pathologic response and recurrence-free survival","volume":"30","author":"Ma","year":"2024","journal-title":"Clin Cancer Res"},{"key":"key20260514105607_b37-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"1596004","DOI":"10.1080\/2162402X.2019.1596004","article-title":"Interaction of tumor-associated macrophages and cancer chemotherapy","volume":"8","author":"Larionova","year":"2019","journal-title":"Oncoimmunology"},{"key":"key20260514105607_b38-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41571-021-00507-y","article-title":"Intratumoural administration and tumour tissue targeting of cancer immunotherapies","volume":"18","author":"Melero","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"key20260514105607_b39-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1172\/JCI43656","article-title":"Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice","volume":"121","author":"Lesterhuis","year":"2011","journal-title":"J Clin Invest"},{"key":"key20260514105607_b40-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"101043","DOI":"10.1016\/j.neo.2024.101043","article-title":"Treatment options for tumor progression after initial immunotherapy in advanced non-small cell lung cancer: A real-world study","volume":"57","author":"Li","year":"2024","journal-title":"Neoplasia"},{"key":"key20260514105607_b41-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"115623","DOI":"10.1016\/j.ejca.2025.115623","article-title":"Sinonasal intestinal-type adenocarcinoma: Multi-institutional retrospective analysis based on 440 patients with long-term follow-up","volume":"226","author":"Dallan","year":"2025","journal-title":"Eur J Cancer"},{"key":"key20260514105607_b42-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/hed.23900","article-title":"Long-term follow-up of 123 patients with adenocarcinoma of the sinonasal tract treated with endoscopic resection and postoperative radiation therapy","volume":"38","author":"Camp","year":"2016","journal-title":"Head Neck"},{"key":"key20260514105607_b43-ol-31-6-15571","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1002\/hed.28171","article-title":"Sinonasal intestinal-type adenocarcinoma in the Netherlands: A nationwide study (2008\u20132022)","volume":"47","author":"van de Velde","year":"2025","journal-title":"Head Neck"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:56:13Z","timestamp":1778745373000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,4,2]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15571","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]}}}